Terkko Navigator / Prostate Cancer and Prostatic Diseases

Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis

Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia

Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials

Active surveillance in intermediate-risk prostate cancer with PSA 10–20 ng/mL: pathological outcome analysis of a population-level database

Hospital volume and outcomes after radical prostatectomy: a national population-based study using patient-reported urinary continence and sexual function

Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs

Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England

Supervised exercise therapy compared with no exercise therapy to reverse debilitating effects of androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis

Artificial intelligence for target prostate biopsy outcomes prediction the potential application of fuzzy logic

Comment on: The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

Racial disparities in prostate cancer among black men: epidemiology and outcomes

Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection

Initial Prostate Health Index (phi) and phi density predicts future risk of clinically significant prostate cancer in men with initial negative prostate biopsy: a 6-year follow-up study

Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223

Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

Correction: Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE−/−:Ins2+/Akita mouse model

EXIT from TRansrectal prostate biopsies (TREXIT): sepsis rates of transrectal biopsy with rectal swab culture guided antimicrobials versus freehand transperineal biopsy

The association between occupational asbestos exposure with the risk of incidence and mortality from prostate cancer: a systematic review and meta-analysis

Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials

The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction

PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer

Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer

Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative

Enhancement of prostate cancer diagnosis by machine learning techniques: an algorithm development and validation study

The microbiome and prostate cancer

Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days’ follow-up

Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer

LUTS/BPH and SARS-COV2: when a misunderstanding in the correct physiopathology results in incorrect associations

Drivers of racial disparities in prostate cancer trial enrollment

Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN

Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer

Letter regarding “18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review”

Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis

Correction: One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia

Correction to: Advances in PSMA-targeted therapy for prostate cancer

Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level

The obesity paradox in metastatic castration-resistant prostate cancer

A transcriptomic model for homologous recombination deficiency in prostate cancer

Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?

Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate

Correction: Public interest in dietary supplements for prostate cancer prevention

Exercise medicine in men with prostate cancer: breaking barriers to increase participation

Prostate cancer and the human papilloma virus: causative association, role of vaccines, and the impact of the COVID-19 pandemic

Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24

Re: Trends and practices for managing low-risk prostate cancer: A SEER-Medicare study

Can there be consensus on whether vasectomy is a prostate cancer risk factor?

Trends and practices for managing low-risk prostate cancer: a SEER-Medicare study

Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function

Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer